Calquence, Acalabrutinib 100 mg capsules, 30 capsules — generic Indications for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL). Targeted cancer therapy. Drug delivery from Europe: +380996042415, Viber, WhatsApp.
Indications
Calquence is indicated as monotherapy or in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphocytic leukemia (CLL).
Calquence is indicated as monotherapy for the treatment of adult patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
No reviews yet